Shell Asset Management CO Amphastar Pharmaceuticals, Inc. Transaction History
Shell Asset Management CO
- $2.9 Billion
- Q2 2025
A detailed history of Shell Asset Management CO transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 4,173 shares of AMPH stock, worth $93,934. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,173
Previous 4,633
9.93%
Holding current value
$93,934
Previous $134,000
28.36%
% of portfolio
0.0%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding AMPH
# of Institutions
257Shares Held
33.8MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$134 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$54.5 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$49.8 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$36.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$30.5 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.1B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...